The Naicons' team

What differentiates us from our competitors is our people and our purpose. To get to know us, just keep reading.

 

The Naicons' team

What differentiates us from our competitors is our people and our purpose. To get to know us, just keep reading.

Stefano Donadio, PhD

Founder, CEO, & President of the Board

Founder and CEO. Over 30-year industrial experience in large, medium-size and startup companies involved in antibiotic discovery and development. His experience spans from drug discovery and development to company creation and management. He has contributed to developing the production processes for dalbavancin (marketed in 2014) and ramoplanin (in phase III clinical studies). He is the author of over 140 publications and patent applications in the fields of antibiotics and antibiotic-producing bacteria. He holds a degree in Chemistry from The University of Naples, Italy, with post-doctoral experience at Johns Hopkins University and The University of Wisconsin-Madison.

Sonia Maffioli, PhD

Co-Founder, & Chemistry Director

Co-Founder and Chemistry Director. Over 20-year industrial experience in medium-size and startup companies involved in antibiotic discovery and development. Her experience spans from early drug discovery to the development of drug candidates. She is the author of over 40 publications and patent applications in the fields of drug discovery. She holds a Chemistry degree with post-graduate training in Synthetic Chemistry from The University of Milan.

Margherita Sosio, PhD

Co-founder, Microbiology Director, & Board Member

Margherita Sosio is co-founder and Microbiology Director at Naicons Srl. She brings more than 30 years of senior-level leadership experience in medium-size and startup companies involved in antibiotic discovery and development. Her experience spans from technology development to screening to optimization of production processes. She has authored over 80 publications and patent applications in the field of antibiotics. She holds a degree in Agricultural Sciences from the University of Milan, with post-doctoral experience at ETH, Zürich.

Ermenegildo Beghé

Co-Founder, CFO, & Board Member

Co-founder and CFO. He has a consolidated experience in finance, controlling, project management, organization, and M&A. Over the past ten years he has been a financial and strategic advisor for several companies in various fields of business. He served previously as CFO in two high tech listed companies, Brainpower and Biosearch, where he also contributed to very successful deals. He holds a degree in economics from Bocconi University, Milan.

Marco Brughera, DVM

Board Member

Dr. Brughera is Group CEO of Leadiant Biosciences a global fully integrated Orphan/Rare Disease company. He previously has held several positions for the Sigma-Tau Group, including Corporate R&D Managing Director. He drove the commercial revival of a lead oncology product line resulting in its successful sale for a total of around $900M. He also successfully out-licensed the Defibrotide US rights to Jazz Pharmaceuticals.

Mattia Monga

Advisory Board Member

Mattia Monga is currently an associate professor at Università degli Studi di Milano, Italy. His research interests are mainly in the field of software engineering, system security, and computer science education. The final goal of his research is to improve the overall quality of software products by making them more flexible, understandable, and reliable. He teaches a “Programming in Python” course in the “Quantitative Biology” master program of his university. He has several publications behind him and his experience in informatics is what NAICONS needs to broaden its views.

Justin van der Hooft

Advisory Board Member

Since January 2020, Justin van der Hooft has been an assistant professor at Wageningen University, the Netherlands. His research vision is to bridge the gap between what we can see in metabolomics profiles to what we can actually learn from them. His group is working on computational metabolomics methods and tools to improve metabolite annotation in untargeted metabolomics experiments, in particular for natural product discovery. The overarching aim of his research is to better understand the chemical language of nature, so we can stimulate beneficial interactions to create more resilient ecosystems, such as by finding the rightly composed soil microbiome that result in drought-tolerant plants. Justin has always been fascinated by the chemical diversity in nature, and this bridges nicely to what NAICONS is doing when mining for novel bioactive molecules in its large bacterial strain collection.

Luca Spampinato

Advisory Board Member

Luca has a degree in Physics from the University of Milan, is a computer scientist and entrepreneur. He has co-founded several companies (Brainpower, Workinvoice, DevAls, Stockflix and Quinary, one of the first European artificial intelligence start-ups) and has carried out important research activities in the field of IT systems architecture and artificial intelligence, with over 30 publications behind him. His knowledge in computer science, his business experience, and his specialization in AI, will be extremely important for the development of the micro4all platform.

CONTACT US